Stative verbs and French Verb-Noun compounds: a discreet preference
Lexique · 01.12.2018 · (23) · 90-130
DOI: 10.54563/lexique.789 ↗Kurz gefasst
Fachartikel in der Zeitschrift Lexique, online erschienen am 01.12.2018. Verfasst von Florence Villoing. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
This paper deals with French nominal Verb-Noun compounds formed on stative verb bases. We assume that word-formation schemas have access to the aspectual and argumental properties of the base verbs and impose fine-grained restrictions on their input. Contrary to what is usually claimed, the study argues that Verb-Noun compounding in French (and probably in other Romance languages) is compatible not only with dynamic verbs but also with stative ones that construct Verb-Noun compounds of high-frequency. These stative verbs are ambiguous between two readings, and verbs can have either a stative or a dynamic structure. Verb-Noun compounding generally prefers the stative verb that systematically corresponds to the class of “pure” stative (that is to say, Kimian-states). The study establishes a link between the aspectual values of the base-verb and the interpretation of VN compounds: VNs on stative base-verbs never form Agent and Instrument nominals but only Experiencer, Means or Location nominals. The inverse prediction also holds: VNs based on the dynamic agentive construction of ambiguous verbs can be interpreted as Agent or Instrument nominals but not as Experiencer or Means nominals.
Zitieren
APA
Villoing, F. (2018). Stative verbs and French Verb-Noun compounds: a discreet preference. Lexique, 90-130. https://doi.org/10.54563/lexique.789
Vancouver
Villoing F. Stative verbs and French Verb-Noun compounds: a discreet preference. Lexique. 2018:90-130. doi:10.54563/lexique.789
BibTeX
@article{Villoing2018,
author = {Villoing, Florence},
title = {Stative verbs and French Verb-Noun compounds: a discreet preference},
journal = {Lexique},
year = {2018},
number = {23},
pages = {90--130},
doi = {10.54563/lexique.789}
}
EUVIMED